#IDIBELLseminars: Deciphering the clinical and biological implications of BRCA2 mutant prostate cancer
My research aim is to improve the outcomes of prostate cancer patients by understanding the biology behind…
International Open Access Week 2022 – Webinars
-
from 24 to 30 October
#IDIBELLfellows: Romina Miranda / Marta Valle
07/10/2020 15:00-16:00
Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting
#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor
Ernest Nadal
Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge
09/10/2020 13:00-14:00
Microsoft Teams Meeting
Career Day 2020
21/10/2020 -
21-22 October 2020
This event is being held online
La recerca en temps de pandèmia
Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich
21/10/2020 19:00-
VII Programa de excelencia en el abordaje del paciente con EM de alta actividad
Unitat EM HUB
22/10/2020 -
22-23 Octubre 2020
Sala d’actes Bellvitge University hospital 9.00h
#IDIBELLconnect: RANK a novel therapeutic target in breast cancer
Speaker Eva Gonzalez-Suarez
Transformation and Metastasis Group, Oncobell Program
06/11/2020 13:00-14:00
PhD Day 2020
12/11/2020 -
12-13 November 2020
this event is being held online
#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies
Rafael Máñez
Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital
20/11/2020 13:00-14:00
Microsoft Teams Meeting
Thesis: Osteoarticular infections: insights on bacteraemic clinical forms and antimicrobial alternatives against Pseudomonas aeruginosa from a translational perspective
By Joan Gómez Junyent
Directors: Javier Ariza Cardenal i Oscar Murillo Rubio
24/11/2020 12:00-
Xerrades Sinergia
Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher
28/11/2020 10:00-19:00
Online i en directe:
https://sinergia.l-h.cat/
#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond
Antonio Gentilella
Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona
04/12/2020 13:00-14:00
Microsoft Teams Meeting
#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses
Juan Jose Rojas
Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona
18/12/2020 13:00-14:00
Microsoft Teams Meeting
- 1
- 2
- 3
- …
- 32
- Entrades següents »
EMBO Workshop: Cancer immunometabolism
29 November – 1 December 2021 | Sitges, Barcelona, Spain Tumor cells undergo metabolic changes to cope…
#IDIBELLfellows: Bernd Kuebler / Jorge L. Castillo Robles
Generation of clinical grade hIPSCs from homozygous haplotype cord blood samples Bernd Kuebler Pluripotent Stem Cell Therapy…
Thesis: Environmental and bystanders’ exposure to secondhand aerosols of electronic cigarettes in the European population
Environmental and bystanders’ exposure to secondhand aerosols of electronic cigarettes in the European population Thesis by Beladenta…
#IDIBELLfellows: Enrique Almanza / Marta Cadevall
Plasma metabolome changes after a lifestyle intervention for weight loss in metabolically healthy obese individuals Enrique Almanza…
#IDIBELLconnect: Quantitative live imaging reveals a phagocytic program that protects the early embryo
Errors leading to cell death during early embryogenesis are the main cause of human preimplantation developmental failures….
#IDIBELLseminars: Genome engineering technologies applied to standardisation
The National Institute for Biological Standards and Control (NIBSC, an agency of the Department of Health and…
Heterogeneity, cross-talks and origin of pancreatic cancer: Insights from the transcriptome and methylome of purified cell populations
Desmoplasia is a hallmark of pancreatic ductal adenocarcinoma (PDAC), still one of the most deadly cancer types….
#IDIBELLfellows: Mariona Chicón / Sergi Fernández
Deciphering the metastatic process of Ewing sarcoma Mariona Chicón Sarcoma Group Oncological outcomes of…
#IDIBELLfellows: Carolina Martínez Herráez / Cristina Moreta
Anabolic storage in ribosome biogenesis addicted cancer: The 40S-LARP1 complex Carolina Martínez Herráez Metabolism and Cancer Group…
- « Entrades anteriors
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 32
- Entrades següents »